文献速递临床试验与 GCP真实世界研究与卫生经济

肺癌筛查中整合数字化与临床方法的戒烟干预:随机对照试验研究方案

An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-11-28

本研究为三臂随机对照试验,计划纳入1650名接受肺癌筛查的吸烟者,比较常规照护(询问-建议-转介)、数字化戒烟干预(网页+短信)及数字化干预联合戒烟治疗专家咨询的效果,主要结局为随机化后12个月经生化确认的戒烟率,并评估成本效益与可行性。

要点

  • 数字化戒烟干预(网页+短信)在老年人群中可行,可能适用于肺癌筛查项目。
  • 主动转介模式(如修改电子健康记录自动链接吸烟者至治疗)可提高戒烟治疗利用。
  • 联合数字化与临床干预可能提高戒烟率,但成本效益或可行性可能低于单独数字化干预。

核心结论

  • 数字化干预的可扩展性和可持续性可能是肺癌筛查项目主动吸引大量吸烟者参与有效戒烟治疗的最具成本效益和可行的方法。
  • 预期联合数字化/临床干预的戒烟率高于单独数字化干预,但对肺癌筛查项目而言可能成本效益较低或可行性较差。

研究设计与样本

  • 三臂随机对照试验,在随机化后1、3、6、12个月重复测量,计划随机化1650名接受临床肺癌筛查的吸烟者。
  • 干预组分别为:常规照护对照组(询问-建议-转介)、数字化戒烟干预(网页+短信)、数字化干预联合戒烟治疗专家咨询。

主要发现

  • 主要结局为随机化后12个月经生化确认的戒烟率。
  • 大型试验和系统综述已证明数字化戒烟干预(网页和短信)有效、长期可持续、可扩展且成本高效。
  • 老年人中数字化技术的使用已很普遍,使该方法在肺癌筛查项目中可行。

关键数值与推荐

  • 随机化1650名吸烟者至三组:常规照护(询问-建议-转介)、数字化干预(网页+短信)、数字化干预联合戒烟治疗专家咨询。
  • 主要结局为随机化后12个月经生化确认的戒烟。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Delivering effective tobacco dependence treatment that is feasible within lung cancer screening (LCS) programs is crucial for realizing the health benefits and cost savings of screening. Large-scale trials and systematic reviews have demonstrated that digital cessation interventions (i.e. web-based and text message) are effective, sustainable over the long-term, scalable, and cost-efficient. Use of digital technologies is commonplace among older adults, making this a feasible approach within LCS programs. Use of cessation treatment has been improved with models that proactively connect smokers to treatment rather than passive referrals. Proactive referral to cessation treatment has been advanced through healthcare systems changes such as modifying the electronic health record to automatically link smokers to treatment. METHODS: This study evaluates the impact of a proactive enrollment strategy that links LCS-eligible smokers with an evidence-based intervention comprised of a web-based (WEB) program and integrated text messaging (TXT) in a three-arm randomized trial with repeated measures at one, three, six, and 12 months post randomization. The primary outcome is biochemically confirmed abstinence at 12 months post randomization. We will randomize 1650 smokers who present for a clinical LCS to: (1) a usual care control condition (UC) which consists of Ask-Advise-Refer; (2) a digital (WEB + TXT) cessation intervention; or (3) a digital cessation intervention combined with tobacco treatment specialist (TTS) counseling (WEB + TXT + TTS). DISCUSSION: The scalability and sustainability of a digital intervention may represent the most cost-effective and feasible approach for LCS programs to proactively engage large numbers of smokers in effective cessation treatment. We will also evaluate the impact and cost-effectiveness of adding proven clinical intervention provided by a TTS. We expect that a combined digital/clinical intervention will yield higher quit rates than digital alone, but that it may not be as cost-effective or feasible for LCS programs to implement. This study is innovative in its use of interoperable, digital technologies to deliver a sustainable, scalable, high-impact cessation intervention and to facilitate its integration within clinical practice. It will add to the growing knowledge base about the overall effectiveness of digital interventions and their role in the healthcare delivery system. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03084835 . Registered on 9 March 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Graham AL, Burke MV, Jacobs MA, et al. An integrated digital/clinical approach to smoking cessation in lung cancer screening: study protocol for a randomized controlled trial. Trials. 2017. PMID: 29179734. doi:10.1186/s13063-017-2312-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。